hotspot -WSS

hotspot

author：leisure time 2025-09-29 19:06:17 - browse：1

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Stem cell biologist probes earliest stages of human development

WSS

Cord blood banking comes at a high cost to babies

Shifting the focus from loneliness to social health

Biden's 'march

Florida health officials providing scant details on measles cases

Ancient Greek ideas underpin modern concepts of pregnancy

State of the Union pitch: Bigger Medicare drug price negotiations

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA's Pazdur wants cancer trials to range beyond China alone

DIEP, the 'gold standard' of breast reconstruction, is under threat

Families look for replacement for GSK asthma drug Flovent

DIEP, the 'gold standard' of breast reconstruction, is under threat

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Affirmative action in medical school literally saved lives

IVF doctors demand details after CooperSurgical lawsuit

leisure time

Lack of health data on LGBTQ+ people has serious consequences

Microsoft's Peter Lee: Generative AI could help doctors be more human

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

First over

First over

Ancient Greek ideas underpin modern concepts of pregnancy

focus

leisure time

hotspot

explore